GO:0051019 mitogen-activated protein kinase binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051019 (mitogen-activated protein kinase binding) is a molecular function defined as binding to a mitogen-activated protein kinase (MAPK).
• MAPK binding is mediated by docking motifs, including D-motifs and DEF motifs, that tether MAPKs to substrates, scaffolds, phosphatases, and regulators.
• Scaffold proteins such as the JIP group and POSH assemble multiprotein complexes through MAPK binding to coordinate JNK and other MAPK cascades [2,7].
• MAPK binding controls signaling specificity, subcellular localization, and feedback regulation, as shown for MKP-3 activation by ERK2 and MKK3/MKK6 regulation in Gq signaling [5,6].
• Dysregulated MAPK binding contributes to human disease, including cancer, inflammatory disorders, and pregnancy complications such as preeclampsia [4,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of MAPK-binding interfaces and their downstream phenotypes [1,2,7].
Description
Mitogen-activated protein kinase (MAPK) binding (GO:0051019) is a molecular function that describes the selective physical interaction between a protein and a MAPK enzyme. MAPKs are central signaling kinases that convert extracellular cues into cellular responses, and their binding partners determine where, when, and how these signals are transmitted [1,2]. The QuickGO definition of GO:0051019 is binding to a mitogen-activated protein kinase, a function that is distinct from catalytic phosphorylation and instead reflects recognition, anchoring, or scaffolding. Researchers study this term because MAPK binding interfaces are critical for signaling fidelity and are increasingly recognized as druggable or editable nodes in disease pathways [1,7]. MAPK binding is not a single interaction but a family of interactions mediated by short linear motifs, including docking (D) motifs and DEF motifs, that engage the MAPK catalytic domain outside the active site. These motifs allow MAPKs to bind substrates, phosphatases, scaffolds, and upstream regulators, thereby shaping signal duration and amplitude [1,6]. For example, the phosphatase MKP-3 is catalytically activated by binding to ERK2, illustrating how MAPK binding can directly regulate enzyme activity. Similarly, scaffold proteins such as JIP and POSH use MAPK binding to assemble multiprotein complexes that direct JNK activation [2,7]. Because MAPK binding controls fundamental processes such as proliferation, differentiation, apoptosis, and immune responses, it is relevant to cancer, inflammatory diseases, and developmental disorders [4,7,8]. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0051019, its mechanisms, key genes, disease links, and experimental methods for functional validation [1-8].
mitogen-activated protein kinase binding At A Glance
| GO ID | GO:0051019 |
|---|---|
| GO term | mitogen-activated protein kinase binding |
| Ontology | molecular_function |
| Synonym | MAPK binding; MAP-kinase anchoring activity; MAP kinase binding |
| Major function | Selective binding to MAPK enzymes to anchor, scaffold, or regulate signaling complexes [1,2] |
| Definition source | QuickGO definition: Binding to a mitogen-activated protein kinase |
| Example interactors | JIP scaffold proteins, POSH, MKP-3, MKK3/MKK6 pathway components [2,5,6,7] |
| Structural basis | Docking motifs (D-motifs, DEF motifs) engaging the MAPK catalytic domain outside the active site [1,3] |
| Disease relevance | Cancer, inflammatory signaling, preeclampsia, and apoptosis-related pathways [4,7,8] |
What Is GO:0051019?
GO:0051019 (mitogen-activated protein kinase binding) is a molecular function term defined by QuickGO as binding to a mitogen-activated protein kinase. It encompasses the selective, non-covalent association of a protein with any MAPK family member, including ERK, JNK, and p38 kinases [1,3]. This function is mediated by defined docking motifs and structural interfaces rather than by catalytic activity, and it serves to localize, scaffold, or regulate MAPK signaling complexes [1,2].
Why Is mitogen-activated protein kinase binding Important in Cell Biology?
MAPK binding is important because it determines the specificity, localization, and duration of MAPK signaling, which controls cell fate decisions such as proliferation, differentiation, and apoptosis [1,2]. Disruption of MAPK binding interfaces can rewire signaling networks and contribute to diseases including cancer, inflammatory conditions, and pregnancy disorders [4,7,8]. Understanding GO:0051019 therefore provides mechanistic insight into how cells decode extracellular signals and offers targets for therapeutic intervention and CRISPR-based functional studies [1,7].
• Defines signaling specificity by tethering MAPKs to selected substrates and scaffolds.
• Controls subcellular localization of MAPK complexes, including nuclear and cytoskeletal pools [2,7].
• Regulates the activity of MAPK phosphatases such as MKP-3 through direct binding.
• Coordinates stress-activated JNK signaling through scaffold proteins like POSH and JIP [2,7].
• Modulates immune and inflammatory responses, including IL-12-induced IFN-gamma expression via p38.
• Contributes to pregnancy-related pathology, as MAPK signaling is downregulated in preeclampsia placentas.
• Provides docking interfaces that can be targeted by peptide or small-molecule inhibitors.
• Enables CRISPR-based dissection of binding motifs in disease-relevant pathways [1,7].
• Links upstream Gq signaling to MKK3/MKK6 regulation in parallel cascades.
• Supports biomarker and drug discovery efforts in oncology and inflammation [4,7].
Molecular Mechanism of mitogen-activated protein kinase binding
Docking motif recognition
In simple terms: MAPK binding often starts when a short sequence motif on a partner protein fits into a pocket on the MAPK surface.
MAPK binding is frequently mediated by short linear docking motifs, such as D-motifs and DEF motifs, that engage the MAPK catalytic domain outside the active site. Proteome-wide screening has identified many docking motifs and interactors, revealing that MAPK binding is a widespread and modular function. These motifs provide specificity by matching particular MAPK family members with selected partners.
Scaffold complex assembly
In simple terms: Scaffold proteins hold several kinases together so that signals pass efficiently from one to the next.
Scaffold proteins such as the JIP group and POSH use MAPK binding to assemble multiprotein complexes that coordinate kinase cascades [2,7]. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis, demonstrating how MAPK binding organizes signaling modules. The JIP group of scaffold proteins similarly organizes MAPK pathways, influencing signal strength and duration.
Regulation of phosphatase activity
In simple terms: Some phosphatases are switched on only after they bind to a MAPK.
Binding to ERK2 catalytically activates the phosphatase MKP-3, showing that MAPK binding can directly regulate enzyme activity. This mechanism provides negative feedback, because activated MKP-3 can dephosphorylate and inactivate MAPKs. Thus, MAPK binding is not only a tethering event but also a regulatory switch.
Pathway-specific regulation by upstream kinases
In simple terms: Upstream signals can tune MAPK binding and activation in parallel branches.
MKK3 and MKK6 are regulated in parallel within Gq-signaling cascades, illustrating how upstream inputs shape MAPK pathway output. The p38 MAPK is required for IL-12-induced IFN-gamma expression, linking MAPK binding-dependent signaling to immune gene regulation. These examples show that MAPK binding interfaces integrate diverse upstream cues [4,5].
Structural determinants of MAPK recognition
In simple terms: The three-dimensional shape of the MAPK determines which partners it can bind.
The crystal structure of p38 MAPK revealed key features of the MAPK fold that support interactions with binding partners. Structural knowledge of MAPK surfaces helps explain how docking motifs achieve selectivity and how mutations can disrupt binding [1,3]. This structural framework is essential for designing point-mutation and knock-in experiments that test binding interfaces [1,3].
Key Genes Involved in GO:0051019 mitogen-activated protein kinase binding
The following genes and proteins are experimentally linked to mitogen-activated protein kinase binding (GO:0051019) and its regulatory complexes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAPK1 (ERK2) | MAPK family kinase that binds substrates and phosphatases | Model for docking motif and MKP-3 activation studies [1,6] |
| MAPK14 (p38 alpha) | Stress-activated MAPK with defined crystal structure | Structural and functional studies of MAPK binding interfaces [3,4] |
| MAPK8 (JNK1) | JNK family kinase in stress and apoptosis signaling | Scaffold-dependent JNK activation via POSH and JIP [2,7] |
| MAPK9 (JNK2) | JNK family kinase in stress responses | Scaffold complex assembly and signaling specificity [2,7] |
| MAPK3 (ERK1) | MAPK family kinase in proliferation signaling | Docking motif screening and interactome studies |
| DUSP6 (MKP-3) | MAPK phosphatase activated by ERK2 binding | Feedback regulation of MAPK signaling |
| MAP2K3 (MKK3) | Upstream kinase in p38 pathway | Parallel regulation in Gq signaling |
| MAP2K6 (MKK6) | Upstream kinase in p38 pathway | Parallel regulation in Gq signaling |
| MAPK8IP1 (JIP1) | Scaffold protein for JNK module | Scaffold assembly and MAPK binding |
| MAPK8IP2 (JIP2) | Scaffold protein for JNK module | Scaffold assembly and MAPK binding |
| MAPK8IP3 (JIP3) | Scaffold protein for JNK module | Scaffold assembly and MAPK binding |
| SH3RF1 (POSH) | Scaffold for JNK activation in apoptosis | Multiprotein complex assembly |
| IL12A | Cytokine subunit linked to p38-dependent IFN-gamma expression | Immune signaling and MAPK binding |
| IL12B | Cytokine subunit linked to p38-dependent IFN-gamma expression | Immune signaling and MAPK binding |
| IFNG | Cytokine whose expression requires p38 MAPK | Readout of p38-dependent signaling |
| GNAQ | Gq alpha subunit upstream of MKK3/MKK6 | Gq signaling and MAPK regulation |
| DUSP1 | MAPK phosphatase family member | Feedback regulation of MAPK pathways |
How Is mitogen-activated protein kinase binding Regulated?
MAPK binding is regulated at multiple levels. Docking motif availability can be controlled by phosphorylation, conformational changes, or competing interactions, as revealed by proteome-wide screening of MAPK docking motifs and interactors. Scaffold proteins such as JIP and POSH regulate the assembly and localization of MAPK complexes, thereby influencing signal duration and specificity [2,7]. Phosphatases like MKP-3 provide negative feedback through MAPK binding-dependent activation. Upstream kinases such as MKK3 and MKK6 are regulated in parallel within Gq-signaling cascades, further tuning MAPK binding and pathway output. In disease contexts, MAPK signaling downregulation has been observed in preeclampsia placentas, indicating that MAPK binding and pathway activity are subject to physiological regulation.
mitogen-activated protein kinase binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SH3RF1 (POSH) | Apoptosis and cancer signaling | Knockout and point-mutation models of JNK scaffold binding |
| MAPK14 (p38 alpha) | Inflammation and immune regulation | Knockout and knock-in models of p38 binding interfaces [3,4] |
| DUSP6 (MKP-3) | MAPK feedback dysregulation | Point-mutation models of ERK2 binding and phosphatase activation |
| MAP2K3/MAP2K6 | Gq signaling and stress responses | Knockout and overexpression models of parallel MKK regulation |
| MAPK8IP1-3 (JIPs) | JNK signaling and neuronal stress | Knockout and tagged knock-in models of scaffold assembly |
Cancer and apoptosis signaling
MAPK binding interfaces are central to signaling pathways that control cell survival and apoptosis. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis, and dysregulation of such complexes can contribute to cancer cell survival or death decisions. Docking motif interactions identified by proteome-wide screening provide a framework for understanding how MAPK binding specificity may be altered in tumors.
Inflammatory and immune disorders
The p38 MAPK is required for IL-12-induced IFN-gamma expression, linking MAPK binding-dependent signaling to immune activation. Disruption of MAPK binding interfaces could therefore alter cytokine responses and inflammatory outcomes. MKK3 and MKK6 regulation in Gq signaling further connects MAPK binding to inflammatory and stress pathways.
Pregnancy complications
Downregulation of a MAPK signaling pathway has been reported in the placentas of women with preeclampsia, suggesting that altered MAPK binding and signaling contribute to this pregnancy disorder. This finding highlights the physiological importance of MAPK pathway regulation in reproductive biology.
From mitogen-activated protein kinase binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate docking motif mediate MAPK binding? | Point-mutation knock-in of the motif in the endogenous locus |
| Is a scaffold protein required for MAPK complex assembly? | CRISPR knockout of the scaffold gene followed by interaction proteomics [2,7] |
| Does MAPK binding regulate phosphatase activity? | Knock-in of binding-deficient MKP-3 and activity assays |
| How does MAPK binding affect immune gene expression? | Knockout of p38 pathway components and IFN-gamma readouts |
| What is the localization of MAPK complexes? | Tagged knock-in of MAPK or scaffold with fluorescent tags [1,2] |
| Can overexpression of a binding partner rewire signaling? | Overexpression cell models with phospho-MAPK profiling [5,7] |
How to Study the mitogen-activated protein kinase binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Proteome-wide docking motif screening | MAPK docking motifs and interactors | Discovery of MAPK binding partners |
| Affinity purification mass spectrometry | Physical interactions with MAPKs | Validation of binding complexes [1,2] |
| Crystal structure analysis | Structural basis of MAPK recognition | Modeling binding interfaces |
| Phospho-MAPK immunoblotting | MAPK pathway activation | Functional readout of binding perturbations [5,6] |
| Kinase activity assay | Catalytic activity of MAPK or phosphatases | Feedback regulation studies |
| Fluorescence imaging | Subcellular localization of complexes | Scaffold and MAPK dynamics [2,7] |
| Cytokine expression assays | IFN-gamma and immune readouts | p38-dependent immune signaling |
| Placental signaling profiling | MAPK pathway activity in tissue | Preeclampsia research |
Interaction proteomics and docking motif screening
Proteome-wide screening for MAPK docking motifs and interactors enables systematic identification of proteins that bind MAPKs. Affinity purification coupled to mass spectrometry can validate candidate interactions and map binding interfaces. These methods are essential for defining the scope of GO:0051019 in a given cell type.
Structural biology and modeling
Crystal structures such as that of p38 MAPK provide templates for modeling MAPK binding interfaces. Structural analysis helps predict how point mutations affect docking motif recognition [1,3]. These approaches guide the design of binding-deficient or binding-enhanced mutants [1,3].
Phospho-signaling assays
Phospho-MAPK immunoblotting and kinase activity assays measure pathway output following perturbation of MAPK binding [5,6]. Such assays can reveal feedback regulation by phosphatases like MKP-3. They are also used to assess p38-dependent gene expression such as IFN-gamma.
Imaging of MAPK complexes
Fluorescence imaging of tagged MAPK or scaffold proteins reveals subcellular localization of binding complexes [2,7]. Live-cell imaging can track dynamic assembly and disassembly of signaling modules [2,7]. These methods complement biochemical interaction data [1,2].
How CRISPR Can Be Used to Study GO:0051019 mitogen-activated protein kinase binding
Knockout
CRISPR knockout of MAPK binding partners or scaffolds can abolish complex formation and reveal loss-of-function phenotypes [2,7]. For example, knocking out JIP scaffold proteins or POSH can disrupt JNK activation and apoptosis signaling [2,7]. Knockout models are also useful for testing whether a candidate interactor is required for MAPK pathway output.
Point Mutation
Point mutations in docking motifs can selectively disrupt MAPK binding without deleting the entire protein. CRISPR point-mutation models enable precise testing of binding interfaces identified by proteome-wide screening. Such models are valuable for separating binding-dependent from catalytic functions [1,6].
Knock-in
Knock-in of tagged or binding-deficient alleles allows endogenous-level expression and localization studies [1,2]. Tagged knock-in of MAPK or scaffold proteins supports imaging of native complexes [2,7]. Knock-in of disease-associated variants can test their impact on MAPK binding [1,8].
Overexpression
Overexpression of MAPK binding partners can amplify or sequester signaling complexes and reveal dominant effects [5,7]. Overexpression models are useful for testing whether increased binding capacity rewires pathway output [5,7]. They complement knockout and knock-in approaches for causal inference [1,5].
How EDITGENE Supports mitogen-activated protein kinase binding Research
Researchers studying mitogen-activated protein kinase binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or disease phenotype. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in, and overexpression of MAPK binding partners and scaffolds. These models support mechanistic studies of GO:0051019 and its role in cancer, inflammation, and other diseases [1,2,7].
Contact EDITGENE today to design your custom CRISPR model for mitogen-activated protein kinase binding research.
Frequently Asked Questions About mitogen-activated protein kinase binding
What is GO:0051019 mitogen-activated protein kinase binding?
GO:0051019 is a molecular function term defined as binding to a mitogen-activated protein kinase, encompassing selective interactions that anchor, scaffold, or regulate MAPK enzymes.
What genes are involved in mitogen-activated protein kinase binding?
Genes include MAPK1, MAPK3, MAPK8, MAPK9, MAPK14, DUSP6, MAP2K3, MAP2K6, MAPK8IP1-3, and SH3RF1, among others [1,2,5,6,7].
How does MAPK binding control signaling specificity?
MAPK binding uses docking motifs such as D-motifs and DEF motifs to match specific MAPKs with selected substrates, scaffolds, and regulators.
What are the synonyms for GO:0051019?
Synonyms include MAPK binding, MAP-kinase anchoring activity, and MAP kinase binding.
Which diseases are linked to MAPK binding?
MAPK binding is linked to cancer, inflammatory and immune disorders, apoptosis signaling, and pregnancy complications such as preeclampsia [4,7,8].
What is the role of scaffold proteins in MAPK binding?
Scaffold proteins such as JIP and POSH assemble multiprotein complexes through MAPK binding to coordinate kinase cascades and JNK activation [2,7].
How is MAPK binding regulated?
It is regulated by docking motif availability, scaffold assembly, phosphatase feedback such as MKP-3, and upstream kinases like MKK3/MKK6 [1,5,6].
What methods study mitogen-activated protein kinase binding?
Proteome-wide docking motif screening, affinity purification mass spectrometry, structural analysis, phospho-signaling assays, and imaging are commonly used [1,2,3,5,6].
Can CRISPR be used to study MAPK binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of MAPK binding interfaces and their phenotypes [1,2,7].
Why is p38 MAPK binding important in immunology?
p38 MAPK is required for IL-12-induced IFN-gamma expression, linking MAPK binding-dependent signaling to immune gene regulation.
Conclusion
GO:0051019 (mitogen-activated protein kinase binding) defines a central molecular function that shapes the specificity, localization, and regulation of MAPK signaling [1,2]. Through docking motifs, scaffolds, and phosphatases, MAPK binding controls diverse cellular outcomes and is implicated in cancer, inflammation, apoptosis, and pregnancy disorders [4,6,7,8]. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide powerful tools to dissect these interactions and their disease relevance [1,2,7]. Continued research on MAPK binding interfaces will advance both mechanistic understanding and therapeutic targeting [1,7].
References
- 1. Shi G et al.. 2023. Proteome-wide screening for mitogen-activated protein kinase docking motifs and interactors.. Sci Signal 16(767):eabm5518 PMID: 36626580
- 2. Yasuda J et al.. 1999. The JIP group of mitogen-activated protein kinase scaffold proteins.. Mol Cell Biol 19(10):7245-54 PMID: 10490659
- 3. Wilson KP et al.. 1996. Crystal structure of p38 mitogen-activated protein kinase.. J Biol Chem 271(44):27696-700 PMID: 8910361
- 4. Zhang S et al.. 2000. The p38 mitogen-activated protein kinase is required for IL-12-induced IFN-gamma expression.. J Immunol 165(3):1374-80 PMID: 10903740
- 5. Yamauchi J et al.. 2001. Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.. J Biol Chem 276(26):23362-72 PMID: 11304531
- 6. Camps M et al.. 1998. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.. Science 280(5367):1262-5 PMID: 9596579
- 7. Xu Z et al.. 2003. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis.. EMBO J 22(2):252-61 PMID: 12514131
- 8. Hannke-Lohmann A et al.. 2000. Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia.. Obstet Gynecol 96(4):582-7 PMID: 11004363
